419 related articles for article (PubMed ID: 16545725)
21. The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse.
Carlens S; Remberger M; Aschan J; Ringdén O
Biol Blood Marrow Transplant; 2001; 7(1):31-8. PubMed ID: 11215696
[TBL] [Abstract][Full Text] [Related]
22. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
Cook G; Clark RE; Crawley C; Mackinnon S; Russell N; Thomson K; Pearce RM; Towlson K; Marks DI
Biol Blood Marrow Transplant; 2006 Mar; 12(3):293-300. PubMed ID: 16503498
[TBL] [Abstract][Full Text] [Related]
23. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
[TBL] [Abstract][Full Text] [Related]
24. Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusion.
Levenga H; Woestenenk R; Schattenberg AV; Maas F; Jansen JH; Raymakers R; De Mulder PH; van de Wiel-van Kemenade E; Schaap N; de Witte T; Dolstra H
Bone Marrow Transplant; 2007 Sep; 40(6):585-92. PubMed ID: 17637687
[TBL] [Abstract][Full Text] [Related]
25. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
[TBL] [Abstract][Full Text] [Related]
26. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
Mutis T; Aarts-Riemens T; Verdonck LF
Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
[TBL] [Abstract][Full Text] [Related]
27. Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population.
Levine JE; Barrett AJ; Zhang MJ; Arora M; Pulsipher MA; Bunin N; Fort J; Loberiza F; Porter D; Giralt S; Drobyski W; Wang D; Pavletic S; Ringden O; Horowitz MM; Collins R
Bone Marrow Transplant; 2008 Aug; 42(3):201-5. PubMed ID: 18490913
[TBL] [Abstract][Full Text] [Related]
28. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
Chan GW; Gorgun G; Miller KB; Foss FM
Biol Blood Marrow Transplant; 2003 Mar; 9(3):170-6. PubMed ID: 12652467
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions.
Nadal E; Fowler A; Kanfer E; Apperley J; Goldman J; Dazzi F
Exp Hematol; 2004 Feb; 32(2):218-23. PubMed ID: 15102484
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.
Porter DL; Collins RH; Shpilberg O; Drobyski WR; Connors JM; Sproles A; Antin JH
Biol Blood Marrow Transplant; 1999; 5(4):253-61. PubMed ID: 10465105
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation.
Or R; Hadar E; Bitan M; Resnick IB; Aker M; Ackerstein A; Samuel S; Tsirigotis P; Gesundheit B; Slavin S; Shapira MY
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1295-301. PubMed ID: 17162211
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
Sanz Rodríguez C; Steegmann JL; Granda A; de la Cámara R; Figuera A; Arranz R; Gómez-García de Soria V; Alegre A; Fernández-Rañada JM
Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760
[TBL] [Abstract][Full Text] [Related]
33. Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study.
Lewalle P; Triffet A; Delforge A; Crombez P; Selleslag D; De Muynck H; Bron D; Martiat P
Bone Marrow Transplant; 2003 Jan; 31(1):39-44. PubMed ID: 12621505
[TBL] [Abstract][Full Text] [Related]
34. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.
Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL
Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162
[TBL] [Abstract][Full Text] [Related]
35. Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions.
Sairafi D; Remberger M; Uhlin M; Ljungman P; Ringdén O; Mattsson J
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1728-37. PubMed ID: 20542125
[TBL] [Abstract][Full Text] [Related]
36. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
[TBL] [Abstract][Full Text] [Related]
37. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
38. Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions.
Dvorak CC; Gilman AL; Horn B; Jaroscak J; Dunn EA; Baxter-Lowe LA; Cowan MJ
Bone Marrow Transplant; 2009 Dec; 44(12):805-12. PubMed ID: 19421175
[TBL] [Abstract][Full Text] [Related]
39. Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHD.
Roberts MM; Dyson P; Rawling C; Thorp D; Rawling T; White D; Horvath N; Bardy P; Hui CH; Dart GW; To LB; Hughes TP
Cytotherapy; 2003; 5(6):534-41. PubMed ID: 14660049
[TBL] [Abstract][Full Text] [Related]
40. Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.
Klyuchnikov E; Holler E; Bornhäuser M; Kobbe G; Nagler A; Shimoni A; Könecke C; Wolschke C; Bacher U; Zander AR; Kröger N
Br J Haematol; 2012 Oct; 159(2):172-81. PubMed ID: 22909192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]